Red Cells and Iron

This SWG covers the clinical areas of inherited and acquired disorders of the erythrocyte and iron metabolism.

Selection panel and principles

Selection panel
EHA Board — Margarita Guenova
EHA Board — Jose Maria Ribera
Community and Stakeholder Committee — Darko Antic
Diversity, Equity, and Inclusion Taskforce — Mihnea-Alexandru Gaman
Education Committee — Jose Tomás Navarro Ferrando
European Affairs Committee — Julio Delgado
Patient Advocacy Committee — Derek Elston
Research…

Webinars and online groups

EHA Research Mobility Grants

The call for applications is now open

EHA strives to develop the career of young scientists by supporting mobility and facilitating a visit to a research group in another institute.

Acute Lymphocytic Leukemia: impressive results with the monoclonal antibody blinatumomab

The Phase 2 dose-ranging study MT103-206 evaluated the efficacy, safety and tolerability of blinatumomab in adult patients with B-precursor Acute Lymphoblastic Leukemia who had relapsed following treatment with standard front-line chemotherapy or allogeneic stem cell transplant.

Press Release: News on Red Cells and Iron presented at the 18th Congress of the European Hematology Asscociation in Stockholm June 13-16, 2013

Recent evidence suggests that these congenital anaemias are caused by molecular abnormalities in the transport of iron and other molecules and a deeper understanding of these mechanisms may lead to a better knowledge of the normal development of the red…

Advances from genome sequencing are paving the way to personalized treatment for leukemia and pre-leukemia

In acute myeloid leukemia (AML) our understanding of how modifications to DNA molecules that do not result in sequence change (i. e.

Press release: Theme of the Year and Patient Advocacy - 18th Congress of EHA - European Hematology Association

This year for the first time, the EHA congress program is complemented by a dedicated advocacy track. This track combines all patient and policy related sessions into one comprehensive full-day program on Saturday.

Invitation: “Can EU citizens afford their medicines? The economic crisis and access to medicines in Europe“

For more information, please find the full invitation here

Reduction of chemotherapy and PET-guided radiotherapy in advanced-stage Hodgkin lymphoma: the GHSG HD15 trial

Using the multi-agent chemotherapy regimen BEACOPP the GHSG demonstrated significantly better tumor control and overall survival compared to previously used regimens. In addition, the need for radiotherapy in patients with advanced stage Hodgkin lymphoma has been unclear.